527 related articles for article (PubMed ID: 10900353)
1. Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue.
Simpson J; Rezaie P; Newcombe J; Cuzner ML; Male D; Woodroofe MN
J Neuroimmunol; 2000 Aug; 108(1-2):192-200. PubMed ID: 10900353
[TBL] [Abstract][Full Text] [Related]
2. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D
J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of beta-chemokines MCP-1 and RANTES and their receptors CCR1, CCR2, CCR5 in acute rejection and chronic allograft nephropathy of human renal allografts.
Rüster M; Sperschneider H; Fünfstück R; Stein G; Gröne HJ
Clin Nephrol; 2004 Jan; 61(1):30-9. PubMed ID: 14964455
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of monocyte chemotactic protein-1 and CC chemokine receptor 2 in the central nervous system is closely associated with relapse of autoimmune encephalomyelitis in Lewis rats.
Jee Y; Yoon WK; Okura Y; Tanuma N; Matsumoto Y
J Neuroimmunol; 2002 Jul; 128(1-2):49-57. PubMed ID: 12098510
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCR4 in the human brain: potential mechanisms for HIV dementia.
van der Meer P; Ulrich AM; Gonźalez-Scarano F; Lavi E
Exp Mol Pathol; 2000 Dec; 69(3):192-201. PubMed ID: 11115360
[TBL] [Abstract][Full Text] [Related]
6. Selective CC chemokine receptor expression by central nervous system-infiltrating encephalitogenic T cells during experimental autoimmune encephalomyelitis.
Fife BT; Paniagua MC; Lukacs NW; Kunkel SL; Karpus WJ
J Neurosci Res; 2001 Nov; 66(4):705-14. PubMed ID: 11746391
[TBL] [Abstract][Full Text] [Related]
7. A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein.
Calderon TM; Eugenin EA; Lopez L; Kumar SS; Hesselgesser J; Raine CS; Berman JW
J Neuroimmunol; 2006 Aug; 177(1-2):27-39. PubMed ID: 16782208
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases.
Silva TA; Garlet GP; Lara VS; Martins W; Silva JS; Cunha FQ
Oral Microbiol Immunol; 2005 Oct; 20(5):310-6. PubMed ID: 16101967
[TBL] [Abstract][Full Text] [Related]
9. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions.
Balashov KE; Rottman JB; Weiner HL; Hancock WW
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6873-8. PubMed ID: 10359806
[TBL] [Abstract][Full Text] [Related]
10. MCP-1 and CCR2 contribute to non-lymphocyte-mediated brain disease induced by Fr98 polytropic retrovirus infection in mice: role for astrocytes in retroviral neuropathogenesis.
Peterson KE; Errett JS; Wei T; Dimcheff DE; Ransohoff R; Kuziel WA; Evans L; Chesebro B
J Virol; 2004 Jun; 78(12):6449-58. PubMed ID: 15163738
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains.
Xia MQ; Qin SX; Wu LJ; Mackay CR; Hyman BT
Am J Pathol; 1998 Jul; 153(1):31-7. PubMed ID: 9665462
[TBL] [Abstract][Full Text] [Related]
12. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients.
Sørensen TL; Tani M; Jensen J; Pierce V; Lucchinetti C; Folcik VA; Qin S; Rottman J; Sellebjerg F; Strieter RM; Frederiksen JL; Ransohoff RM
J Clin Invest; 1999 Mar; 103(6):807-15. PubMed ID: 10079101
[TBL] [Abstract][Full Text] [Related]
13. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS.
Babcock AA; Kuziel WA; Rivest S; Owens T
J Neurosci; 2003 Aug; 23(21):7922-30. PubMed ID: 12944523
[TBL] [Abstract][Full Text] [Related]
14. Expression of chemokines and chemokine receptors during human renal transplant rejection.
Segerer S; Cui Y; Eitner F; Goodpaster T; Hudkins KL; Mack M; Cartron JP; Colin Y; Schlondorff D; Alpers CE
Am J Kidney Dis; 2001 Mar; 37(3):518-31. PubMed ID: 11228176
[TBL] [Abstract][Full Text] [Related]
15. Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes.
Jalonen TO; Pulkkinen K; Ukkonen M; Saarela M; Elovaara I
J Neurol; 2002 May; 249(5):576-83. PubMed ID: 12021948
[TBL] [Abstract][Full Text] [Related]
16. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study.
McManus C; Berman JW; Brett FM; Staunton H; Farrell M; Brosnan CF
J Neuroimmunol; 1998 Jun; 86(1):20-9. PubMed ID: 9655469
[TBL] [Abstract][Full Text] [Related]
17. T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking.
Kivisäkk P; Trebst C; Liu Z; Tucky BH; Sørensen TL; Rudick RA; Mack M; Ransohoff RM
Clin Exp Immunol; 2002 Sep; 129(3):510-8. PubMed ID: 12197893
[TBL] [Abstract][Full Text] [Related]
18. Expression of beta-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNS.
Rezaie P; Trillo-Pazos G; Everall IP; Male DK
Glia; 2002 Jan; 37(1):64-75. PubMed ID: 11746784
[TBL] [Abstract][Full Text] [Related]
19. Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions.
Simpson JE; Newcombe J; Cuzner ML; Woodroofe MN
J Neuroimmunol; 1998 Apr; 84(2):238-49. PubMed ID: 9628469
[TBL] [Abstract][Full Text] [Related]
20. Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis.
Tanuma N; Sakuma H; Sasaki A; Matsumoto Y
Acta Neuropathol; 2006 Aug; 112(2):195-204. PubMed ID: 16733654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
